UAE Syringe Market to grow with a CAGR of 8.72% to 2028
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Syringe Market.
According to TechSci Research report, “UAE
Syringe Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2018-2028”,
UAE Syringe Market has valued at USD 0.17 billion in 2022 and is anticipated to
witness an impressive growth in the forecast period with a CAGR of 8.72%
through 2028. This can be
due to collaborations and partnerships among leading companies with a diverse
approach to merge the expertise of individual companies and to strengthen their
position.
The focus on preventive healthcare is a
significant driver of the demand for syringes, as it emphasizes the importance
of vaccinations, screenings, and other preventive measures. Preventive
healthcare often involves routine vaccination programs to protect individuals
from various infectious diseases. The administration of vaccines requires
syringes, contributing to a consistent demand. Public health initiatives and
immunization campaigns aimed at preventing the spread of diseases drive the
demand for syringes. These campaigns often target specific age groups or
populations, necessitating the use of syringes for vaccine delivery. Preventive
healthcare includes regular health screenings and diagnostic tests. Many of
these screenings involve blood tests or injections for diagnostic purposes,
requiring the use of syringes.
Preventive healthcare strategies often
include measures to prevent the onset or progression of chronic diseases. Some
preventive interventions, such as certain vaccinations or treatments, involve
the use of syringes. People increasingly seek preventive healthcare measures
before traveling, including vaccinations for diseases prevalent in specific
regions. These travel vaccinations contribute to the demand for syringes.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Syringe Market.”
In October 2022, the
Ministry of Industry and Advanced Technology (MoIAT) announced the signing of
two memoranda of understanding (MoU) totaling AED 260 million ($70.8 million)
between prominent pharmaceutical and medical device companies in the UAE. In
these collaborations, PureHealth, a leading healthcare provider in the UAE and
a participant in the ministry's National ICV Program, will partner with Abu
Dhabi Medical Devices Company (ADMD), a subsidiary of Abu Dhabi National
Industrial Projects. Additionally, Abu Dhabi Ports Group and Abu Dhabi Polymers
Company (Borouge) are involved in establishing a AED 110 million medical
supplies production line in Abu Dhabi. According to the MoU, Borouge will
supply raw materials, while Abu Dhabi Ports Group will offer industrial land in
ICAD 1 for the manufacturing of medical syringes, administration devices, and
blood collection tubes.
Supply
chain disruptions represent a significant challenge in the UAE syringe market,
as they can impact the availability, production, and distribution of syringes.
Disruptions
in the supply chain can lead to shortages of essential raw materials required
for syringe manufacturing. This can hinder production and result in delays in
meeting market demand. Many syringe manufacturers may rely on global supply
chains for raw materials, components, and manufacturing equipment.
International disruptions, such as trade restrictions or geopolitical events,
can affect the seamless flow of these resources. Disruptions in transportation,
whether due to logistics challenges, border restrictions, or other factors, can
lead to delays in the movement of raw materials, finished syringe products, and
components, affecting the overall supply chain. Supply chain disruptions may
impact the production capacity of syringe manufacturing facilities. Factory
closures, workforce shortages, or restrictions on operational activities can limit
the ability to meet market demand.
UAE Syringe Market is
segmented based on Product Type, Material, Usage, End User, and by region.
Based on the Product
Type, UAE Syringe
Market is segmented into General, Specialized, Smart. Specialized syringes refer to syringe
variations designed for specific medical applications, offering features
tailored to meet unique requirements or address specific challenges in
healthcare. These syringes are often developed to enhance safety, improve
precision, or cater to medical procedures.
Based on Region, Abu Dhabi region held the largest share
in the UAE Syringe
Market. The region might have access to
essential resources required for syringe production, such as skilled labor, raw
materials, and advanced technologies. This can be a crucial factor in
establishing and maintaining a competitive edge in the market. Abu Dhabi, as a
major economic and healthcare hub, may have a higher concentration of
healthcare facilities, increasing the demand for medical devices like syringes.
Proximity to end-users can influence the market dynamics. The regulatory
environment in Abu Dhabi might be more favorable for the medical device
industry, providing clear guidelines, streamlined approval processes, and a
supportive framework for companies involved in syringe manufacturing. Abu Dhabi
serves as a global trade hub or has strong trade connections, this can
positively impact the syringe market by facilitating exports and imports, as
well as creating a favorable environment for international collaborations.
Some of the major companies operating in
the UAE Syringe
Market include:
- Becton
Dickinson and Company
- B. Braun
Medical Gulf FZ – LLC
- Medtronic
Meta FZ-LLC
- Nipro
Middle East FZE
- Baxter
Healthcare UAE
- Terumo
Middle East FZE
- Al Magam
Medical Supplies LLC
- Abu Dhabi
Medical Devices Company
- Riomed
Medical Supplies L.L.C
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Syringe.
The growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the UAE Syringe
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
UAE Syringe Market by Product
Type (General (Insulin, Allergy, Tuberculin, Others), Specialized
(Auto-Disable, Active Safety, Passive Safety), Smart), By Material (Plastic,
Glass, Others), By Usage (Reusable, Disposable), By End User (Hospitals &
Clinics, Blood Collection Centers, Diabetes Care Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Syringe Market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide innovative market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in UAE Syringe Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com